ArticleCancer causes & control : CCC1996
Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91.
Article in Cancer causes & control : CCC, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 35 citations in OpenAlex.
- Article
- A nomogram for overall survival of second primary cancers following upper-tract urothelial carcinoma: a SEER population-based study.Translational cancer research · 2024Article
- Renal cell carcinoma and risk of second primary cancer: A Danish nationwide cohort study.Cancer medicine · 2024Article
- Does radiotherapy increase the risk of colorectal cancer among prostate cancer patients? A large population-based study.Journal of Cancer · 2020Article
- Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study.PloS one · 2017Article
- Quadruple primary urogenital cancers - A case report.International journal of surgery case reports · 2017Article
- Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.World journal of urology · 2016Article
- Is there a role for IGF-1 in the development of second primary cancers?Cancer medicine · 2016Review
- Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.PloS one · 2015Article
- Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.Cancer · 2014Article
- Environmental non-occupational risk factors associated with bladder cancer.Actas urologicas espanolas · 2013Review
- Incidence and prognostic significance of second primary cancers in renal cell carcinoma.American journal of clinical oncology · 2013Article
- Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers.World journal of urology · 2008Article
- [Interdisciplinary oncologic after-care exemplified by second primary tumors after bladder carcinoma].Der Urologe. Ausg. A · 2003Article
- Cancer registries in epidemiologic research.Cancer causes & control : CCC · 1996Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Data from the New South Wales (NSW) (Australia) Central Cancer Registry for the period 1972-91 were examined to determine the risk of second primary cancers following an initial invasive cancer of the renal parenchyma (ICD-9 code 189.0), renal pelvis (code 189.1), or prostate (code 185). Eligible cases were restricted to those who had survived for at least two months after diagnosis of the first primary cancer. Expected numbers of cancers were obtained by assuming that subjects experienced the same cancer incidence as prevailed in the corresponding general population and applying gender-, age-, and calendar-specific rates to the appropriate person-years at risk. The relative risk (RR) of a second primary cancer was taken to be the ratio of observed to expected numbers of second cancers. Following prostatic cancer, there was an overall deficit of cancers at all sites combined (RR = 0.79, 95 percent confidence interval [CI] = 0.75-0.84), and no site had a significantly raised RR. Taking this into consideration, there appeared to be a reciprocal relationship of increased risk of prostatic cancer (RR = 1.7, CI = 1.2-2.3) following an initial cancer of the renal parenchyma and of renal parenchymal cancer (RR = 1.2, CI = 0.8-1.7) after cancer of the prostate. An increased risk of bladder cancer occurred following renal parenchymal (RR = 3.4, CI = 1.1-8.0, for women only) as well as after renal pelvic cancer (men: RR = 8.7, CI = 5.4-13; women: RR = 39, CI = 26-56). A tobacco-related pattern of excess risk was seen after renal pelvic cancer but not after cancer of the renal parenchyma. These data illustrate that an excess of second primary cancers may reflect shared etiologic factors or increased medical surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.